성장을 멈추지 마세요

체험은 만족하셨나요?

현재 45,766명이 마이메르시로 공부 중이에요

지식 자료를 소장하고 멋진 의료인으로 성장하세요

Hypertension | 마이메르시 MyMerci
제안하기

뭔가 하고 싶은 말이 있는거야?

0 / 2000

Hypertension

NCLEX Review Guide: Hypertension

Pathophysiology of Hypertension

Definition and Classification

  • Hypertension is defined as persistent elevation of systolic blood pressure ≥130 mmHg and/or diastolic blood pressure ≥80 mmHg based on the American College of Cardiology/American Heart Association guidelines. The classification includes: Normal (< 120/80 mmHg), Elevated (120-129/< 80 mmHg), Stage 1 (130-139/80-89 mmHg), and Stage 2 (≥ 140/90 mmHg).
  • Primary (essential) hypertension accounts for 90-95% of cases with no identifiable cause, while secondary hypertension (5-10% of cases) results from identifiable underlying conditions such as renal disease, endocrine disorders, or medication side effects.

Key Points

  • Current guidelines classify BP ≥130/80 as hypertension (previously 140/90)
  • Most cases are primary/essential with no identifiable cause
  • Secondary causes include renal, endocrine, and medication-induced

Pathophysiological Mechanisms

  • Hypertension develops through multiple physiological mechanisms including increased sympathetic nervous system activity, renin-angiotensin-aldosterone system (RAAS) activation, endothelial dysfunction, and increased vascular resistance. Endothelial dysfunction refers to impaired nitric oxide production leading to vasoconstriction and increased peripheral resistance.
  • Chronic elevation in blood pressure leads to arterial remodeling with medial hypertrophy, resulting in increased arterial stiffness and further elevation of systolic pressure. This creates a vicious cycle that promotes target organ damage in the heart, kidneys, brain, and eyes.

Key Points

  • RAAS activation is a key mechanism in hypertension pathophysiology
  • Endothelial dysfunction contributes to vasoconstriction
  • Arterial remodeling creates a self-perpetuating cycle

Risk Factors and Assessment

Modifiable and Non-modifiable Risk Factors

  • Non-modifiable risk factors include age (risk increases with age), family history (genetic predisposition), race/ethnicity (higher prevalence in African Americans), and gender (higher in males until age 65, then higher in females).
  • Modifiable risk factors include obesity (especially central obesity), high sodium intake (>2300 mg/day), physical inactivity, excessive alcohol consumption, tobacco use, stress, and poor diet (high in saturated fats and low in fruits and vegetables).

Key Points

  • African Americans have higher prevalence, earlier onset, and more severe hypertension
  • Sodium intake >2300 mg/day significantly increases hypertension risk
  • Central obesity strongly correlates with hypertension development

Assessment and Diagnosis

  • Proper blood pressure measurement technique is critical for accurate diagnosis and requires the patient to be seated quietly for 5 minutes, feet flat on floor, arm supported at heart level, using appropriate cuff size (bladder encircling 80% of arm), and averaging 2-3 readings taken 1-2 minutes apart.
  • Diagnostic workup includes comprehensive history (including family history, medications, lifestyle factors), physical examination (fundoscopic exam, cardiac assessment, peripheral pulses), laboratory tests (electrolytes, glucose, lipids, creatinine, urinalysis), and possibly ECG, echocardiogram, or renal ultrasound to assess for target organ damage or secondary causes.

Clinical Scenario

A 58-year-old African American male presents for a routine physical. His blood pressure is measured as 162/94 mmHg. This reading is repeated after 5 minutes and found to be 158/92 mmHg. He reports occasional headaches but is otherwise asymptomatic. He has a BMI of 32, family history of hypertension, and works a high-stress job. What additional assessments should be performed to evaluate for target organ damage?

Answer: This patient requires a comprehensive evaluation including fundoscopic examination to assess for hypertensive retinopathy, cardiac assessment (ECG, possibly echocardiogram) to evaluate for left ventricular hypertrophy, laboratory tests (BUN/creatinine, urinalysis) to assess renal function, and neurological assessment. His stage 2 hypertension, combined with multiple risk factors (obesity, family history, race, stress), places him at high risk for complications.

Key Points

  • Diagnosis requires averaging multiple BP readings from 2+ office visits
  • Appropriate cuff size is essential for accurate measurement
  • Initial evaluation should assess for target organ damage and secondary causes

Pharmacological Management

First-Line Antihypertensive Medications

  • Thiazide diuretics (e.g., hydrochlorothiazide, chlorthalidone) reduce blood pressure by decreasing blood volume through increased sodium and water excretion. They are particularly effective in African American patients, elderly patients, and those with osteoporosis due to decreased calcium excretion.
  • ACE inhibitors (e.g., lisinopril, enalapril) block the conversion of angiotensin I to angiotensin II, reducing vasoconstriction and aldosterone secretion. They are preferred in patients with diabetes, chronic kidney disease, heart failure, or post-myocardial infarction but are contraindicated in pregnancy and should be used cautiously in patients with bilateral renal artery stenosis.
  • Angiotensin II Receptor Blockers (ARBs) (e.g., losartan, valsartan) block angiotensin II receptors, preventing vasoconstriction and aldosterone release. They have similar indications to ACE inhibitors but cause less cough and angioedema, making them suitable alternatives when ACE inhibitors are not tolerated.
  • Calcium Channel Blockers (CCBs) (e.g., amlodipine, diltiazem) reduce blood pressure by blocking calcium influx into vascular smooth muscle cells, causing vasodilation. Dihydropyridine CCBs (amlodipine) primarily affect peripheral vessels, while non-dihydropyridines (diltiazem, verapamil) also affect cardiac conduction.

Comparison of First-Line Antihypertensive Medications

Medication Class Primary Mechanism Preferred Population Major Side Effects Key Considerations
Thiazide Diuretics ↑ Na+ excretion, ↓ blood volume African Americans, Elderly Hypokalemia, hyperglycemia, hyperuricemia Monitor electrolytes; most cost-effective
ACE Inhibitors Block angiotensin II formation Diabetes, CKD, HF, post-MI Dry cough, angioedema, hyperkalemia Contraindicated in pregnancy; monitor K+ and renal function
ARBs Block angiotensin II receptors Diabetes, CKD, ACE-I intolerance Hyperkalemia, dizziness Contraindicated in pregnancy; fewer side effects than ACE-I
CCBs Block Ca2+ influx in smooth muscle African Americans, Elderly Peripheral edema, constipation, gingival hyperplasia Dihydropyridines vs. non-dihydropyridines have different effects

Key Points

  • First-line therapy includes thiazides, ACE inhibitors, ARBs, and CCBs
  • Medication selection should be based on comorbidities and demographic factors
  • ACE inhibitors and ARBs are contraindicated in pregnancy (category D/X)

Second-Line and Combination Therapy

  • Beta-blockers (e.g., metoprolol, carvedilol) reduce blood pressure by decreasing cardiac output and inhibiting renin release. While no longer first-line for uncomplicated hypertension, they remain indicated for patients with coronary artery disease, heart failure, or certain arrhythmias.
  • Combination therapy is indicated when monotherapy fails to achieve target blood pressure, with approximately two-thirds of patients requiring multiple agents. The most effective combinations include a RAAS inhibitor (ACE inhibitor or ARB) with either a CCB or thiazide diuretic, while combining ACE inhibitors with ARBs should be avoided due to increased adverse effects without significant benefit.

Clinical Alert

Never combine ACE inhibitors with ARBs as this dual RAAS blockade increases risk of hyperkalemia, hypotension, and acute kidney injury without providing additional benefit. Similarly, avoid combining potassium-sparing diuretics with ACE inhibitors or ARBs without careful monitoring of potassium levels and renal function.

Key Points

  • Most patients require 2+ medications to achieve BP targets
  • Complementary mechanisms provide synergistic effects
  • Fixed-dose combinations improve adherence and outcomes

Special Considerations in Medication Management

  • Hypertensive urgency (BP >180/120 mmHg without target organ damage) should be treated with oral medications and close follow-up, while hypertensive emergency (severe BP elevation with acute target organ damage) requires immediate IV therapy in an intensive care setting, typically with labetalol, nicardipine, or clevidipine.
  • Resistant hypertension, defined as BP that remains above goal despite adherence to an appropriate 3-drug regimen (including a diuretic), requires evaluation for secondary causes, assessment of medication adherence, and consideration of additional agents such as spironolactone or referral to a hypertension specialist.

Memory Aid: ABCD Approach to Resistant Hypertension

  • Adherence assessment (medication compliance, lifestyle modifications)
  • Blood pressure measurement technique validation
  • Confirm diagnosis (consider white coat hypertension, masked hypertension)
  • Drug interactions and secondary causes evaluation

Key Points

  • Hypertensive emergency requires immediate IV therapy and ICU monitoring
  • Spironolactone is often effective for resistant hypertension
  • Medication non-adherence is the most common cause of treatment failure

Non-Pharmacological Management

Lifestyle Modifications

  • The DASH (Dietary Approaches to Stop Hypertension) diet emphasizes fruits, vegetables, whole grains, lean proteins, and low-fat dairy while limiting saturated fat and sodium. This dietary pattern can reduce systolic BP by 8-14 mmHg, comparable to the effect of some antihypertensive medications.
  • Sodium restriction to <2300 mg/day (ideally 1500 mg/day for high-risk populations) can reduce systolic BP by 5-6 mmHg in hypertensive individuals. This requires reading food labels, avoiding processed foods, and using herbs and spices instead of salt for flavoring.
  • Regular aerobic exercise (150 minutes/week of moderate-intensity or 75 minutes/week of vigorous activity) can lower systolic BP by 5-8 mmHg. Resistance training 2-3 times weekly provides additional benefits but should be combined with aerobic activity.

Key Points

  • DASH diet can reduce SBP by 8-14 mmHg
  • Weight loss of 5-10% can reduce BP by 5-20 mmHg per 10kg
  • Limiting alcohol to ≤1 drink/day for women and ≤2 for men reduces BP

Patient Education and Self-Management

  • Home blood pressure monitoring improves BP control by increasing patient awareness and medication adherence. Patients should be instructed to measure BP at the same time daily, using proper technique, and to maintain a BP log to share with healthcare providers.
  • Medication adherence strategies include simplifying regimens (once-daily dosing, fixed-dose combinations), using pill organizers or smartphone reminders, and addressing patient concerns about side effects or medication costs.

    Teaching Proper Home BP Measurement

  1. Select an automated upper arm device validated by AAMI, ESH, or BHS
  2. Ensure proper cuff size (bladder should encircle 80% of arm)
  3. Instruct patient to sit quietly for 5 minutes before measurement
  4. Position arm at heart level with back supported and feet flat on floor
  5. Take 2-3 readings 1 minute apart and record all values
  6. Measure BP at the same times daily (morning and evening)
  7. Avoid caffeine, exercise, and smoking for 30 minutes prior
  8. Document readings in a log or smartphone app

Key Points

  • Home BP monitoring improves treatment adherence and outcomes
  • Simplifying medication regimens increases compliance
  • Patient education should address barriers to adherence

Complications and Special Populations

Target Organ Damage and Complications

  • Cardiovascular complications include left ventricular hypertrophy (LVH), heart failure, coronary artery disease, and aortic dissection. LVH, an adaptive response to increased afterload, eventually becomes maladaptive and increases risk of arrhythmias, heart failure, and sudden cardiac death.
  • Cerebrovascular complications include ischemic stroke, hemorrhagic stroke, and vascular dementia. Hypertension is the strongest modifiable risk factor for stroke, with each 20/10 mmHg increase in BP doubling stroke risk.
  • Renal complications include chronic kidney disease (CKD) and end-stage renal disease. Hypertension causes nephrosclerosis through glomerular hypertension, endothelial damage, and arteriolar thickening, creating a vicious cycle as kidney damage further elevates BP.
  • Retinal complications include hypertensive retinopathy, characterized by arteriolar narrowing (grade 1), arteriovenous nicking (grade 2), hemorrhages and exudates (grade 3), and papilledema (grade 4). Grades 3-4 indicate malignant hypertension requiring urgent treatment.

Key Points

  • Sustained hypertension damages heart, brain, kidneys, and eyes
  • Each 20/10 mmHg increase doubles cardiovascular risk
  • Early detection and treatment prevents progression of target organ damage

Hypertension in Special Populations

  • Pregnancy-related hypertension includes chronic hypertension (pre-existing), gestational hypertension (after 20 weeks without proteinuria), and preeclampsia (hypertension with proteinuria or end-organ damage after 20 weeks). Preeclampsia requires close monitoring and may necessitate early delivery, while severe cases can progress to eclampsia (seizures) or HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets).
  • Elderly patients often have isolated systolic hypertension due to decreased arterial compliance. Treatment should begin at lower doses with gradual titration to avoid orthostatic hypotension, falls, and electrolyte disturbances. The benefit-risk ratio should be considered in frail elderly patients, with less stringent BP targets sometimes appropriate.
  • Patients with diabetes require more aggressive BP control (target <130/80 mmHg) to reduce risk of microvascular and macrovascular complications. ACE inhibitors or ARBs are preferred first-line agents due to their renoprotective effects, often combined with a thiazide diuretic or CCB.

Clinical Alert

ACE inhibitors and ARBs are contraindicated during pregnancy due to risk of fetal renal malformations, oligohydramnios, and fetal death. Women of childbearing age taking these medications must use reliable contraception and should be switched to safer alternatives (methyldopa, labetalol, nifedipine) if pregnancy occurs or is planned.

Key Points

  • Preeclampsia is a medical emergency requiring prompt intervention
  • Elderly patients require careful dose titration to avoid adverse effects
  • Diabetes with hypertension significantly increases cardiovascular risk

Commonly Confused Points

Hypertension Classifications and Terminology

Comparison of Hypertension Types

Term Definition Clinical Significance Management Approach
Primary (Essential) Hypertension Elevated BP without identifiable cause (90-95% of cases) Multifactorial etiology involving genetic and environmental factors Lifestyle modifications plus pharmacotherapy based on comorbidities
Secondary Hypertension Elevated BP due to identifiable underlying condition Often presents with resistant hypertension or atypical features Treat underlying cause (e.g., renal artery stenosis, pheochromocytoma)
White Coat Hypertension Elevated BP in clinical settings but normal at home Lower cardiovascular risk than sustained hypertension Home BP monitoring, ambulatory BP monitoring, lifestyle changes
Masked Hypertension Normal BP in clinical settings but elevated at home Associated with increased cardiovascular risk Home BP monitoring, ambulatory BP monitoring, treat as sustained HTN
Hypertensive Urgency Severe BP elevation (>180/120) without acute target organ damage Requires prompt but not emergency treatment Oral medications, close follow-up within days
Hypertensive Emergency Severe BP elevation with acute target organ damage Life-threatening condition requiring immediate intervention IV medications in ICU setting, gradual BP reduction

Key Points

  • White coat and masked hypertension require out-of-office BP measurements
  • Urgency vs. emergency is distinguished by presence of acute target organ damage
  • Secondary hypertension should be suspected in young patients or resistant cases

Medication Mechanisms and Side Effects

Commonly Confused Antihypertensive Medications

Medication Comparison Key Differences Side Effect Profiles Clinical Considerations
ACE Inhibitors vs. ARBs ACEIs block angiotensin II formation; ARBs block receptors ACEIs cause dry cough (10-20%); ARBs rarely cause cough Similar efficacy and indications; ARBs preferred if ACEI cough develops
Thiazide vs. Loop Diuretics Thiazides act on distal tubule; loops on ascending loop of Henle Both cause electrolyte imbalances; loops more potent diuresis Thiazides preferred for HTN; loops for HF or CKD with GFR <30
DHP vs. Non-DHP CCBs DHPs (amlodipine) primarily affect vessels; non-DHPs affect heart DHPs: peripheral edema; non-DHPs: bradycardia, constipation Non-DHPs contraindicated with beta-blockers or heart failure
Cardioselective vs. Non-selective Beta-Blockers Cardioselective (metoprolol) primarily affect β1 receptors Non-selective can cause bronchospasm, mask hypoglycemia Cardioselective preferred in diabetes, COPD, or asthma

Memory Aid: "ACE" the Side Effects

Angioedema (rare but serious)

Cough (dry, persistent, non-productive)

Elevated potassium (hyperkalemia)

Key Points

  • ACE inhibitor cough is due to bradykinin accumulation, not a true allergy
  • Dihydropyridine CCBs don't significantly affect heart rate or contractility
  • Beta-blocker selection should consider comorbidities and side effect profiles

Study Tips and NCLEX Preparation

NCLEX Question Strategies

  • When answering NCLEX questions about hypertension, prioritize patient safety by identifying immediate risks (e.g., extremely high BP, signs of target organ damage) before addressing long-term management concerns.
  • For medication questions, remember that patient teaching about common side effects and monitoring requirements is essential nursing care. Focus on major side effects that require intervention (e.g., ACE inhibitor-induced angioedema) rather than minor side effects.

Quick Check: Hypertension Priority Setting

Which patient should the nurse assess first?

  1. Patient with BP 168/94 reporting mild headache
  2. Patient with BP 182/100 who is asymptomatic
  3. Patient with BP 210/118 reporting visual changes and confusion
  4. Patient with BP 150/88 who is non-adherent to medications

Answer: C. The patient with BP 210/118 reporting visual changes and confusion shows signs of possible hypertensive emergency with neurological involvement requiring immediate assessment and intervention.

Key Points

  • Prioritize patients with signs of target organ damage
  • Know therapeutic vs. toxic effects of antihypertensive medications
  • Focus on nursing assessments and interventions rather than just medical management

Common Pitfalls in Hypertension Management

  • Failing to recognize secondary causes of hypertension, especially in patients with resistant hypertension, sudden onset, age <30 years, or severe elevation. Key clues include abnormal electrolytes, renal function, or physical findings suggestive of endocrine disorders.
  • Inappropriate medication combinations, such as dual RAAS blockade (ACE inhibitor + ARB) or combining negative chronotropic agents (beta-blockers + non-dihydropyridine CCBs), which increase adverse effects without proportional benefit.

Memory Aid: "ABCDE" of Hypertensive Emergency Assessment

Alteration in mental status (confusion, lethargy, seizures)

Blurred vision or other visual disturbances

Chest pain or cardiac dysfunction (heart failure)

Dyspnea (pulmonary edema)

End-organ damage (renal failure, papilledema)

Key Points

  • Suspect secondary hypertension in young patients and resistant cases
  • Avoid dual RAAS blockade and other contraindicated combinations
  • Don't lower BP too rapidly in hypertensive emergencies (aim for 25% reduction in first hours)

NCLEX-Style Practice Questions

Question 1:

A 62-year-old patient with hypertension is prescribed lisinopril. Which assessment finding would warrant immediate notification of the provider?

  1. Dry, persistent cough
  2. Serum potassium of 5.2 mEq/L
  3. Facial and lip swelling with difficulty swallowing
  4. Blood pressure of 136/84 mmHg

Answer: C. Facial and lip swelling with difficulty swallowing indicates angioedema, a potentially life-threatening reaction to ACE inhibitors requiring immediate discontinuation and intervention.

Question 2:

A nurse is teaching a patient with newly diagnosed hypertension about the DASH diet. Which meal choice best reflects adherence to this diet?

  1. Grilled chicken sandwich with french fries and diet soda
  2. Baked salmon with brown rice, steamed vegetables, and water
  3. Cheeseburger with a side salad and unsweetened tea
  4. Ham and cheese sandwich with potato chips and fruit juice

Answer: B. Baked salmon with brown rice, steamed vegetables, and water aligns with DASH diet principles: lean protein, whole grains, vegetables, and low sodium.

Question 3:

A patient with hypertension is prescribed hydrochlorothiazide. Which laboratory value should the nurse monitor most closely?

  1. Serum potassium
  2. Blood glucose
  3. Hemoglobin
  4. Liver enzymes

Answer: A. Thiazide diuretics commonly cause hypokalemia, which can lead to cardiac arrhythmias and requires close monitoring.

Key Points

  • Focus on assessment findings that require immediate intervention
  • Know lifestyle modification components and recommendations
  • Understand medication-specific monitoring requirements

Self-Assessment Checklist

Knowledge Assessment

  • Check your understanding of key hypertension concepts with this self-assessment. Mark each item as you master it, and focus additional study on areas where you need improvement.

Hypertension Knowledge Checklist

  • Define hypertension and describe current classification guidelines
  • Explain pathophysiological mechanisms of primary and secondary hypertension
  • Identify modifiable and non-modifiable risk factors
  • Describe proper blood pressure measurement technique
  • Compare and contrast first-line antihypertensive medications
  • Explain nursing considerations for each class of antihypertensive medications
  • Identify appropriate lifestyle modifications for hypertension management
  • Differentiate between hypertensive urgency and emergency
  • Describe target organ damage and complications of hypertension
  • Explain special considerations for hypertension in pregnancy, elderly, and diabetes
  • Identify patient education priorities for hypertension self-management

Key Points

  • Focus on understanding rather than memorization
  • Apply concepts to clinical scenarios
  • Review weak areas with additional practice questions

Remember that hypertension is one of the most common conditions you'll encounter in clinical practice. Mastering these concepts will help you provide evidence-based care to patients across the lifespan. Stay focused on understanding the pathophysiology and clinical reasoning behind interventions rather than just memorizing facts. You've got this!

다음 이론을 계속 학습하려면 로그인하세요.

로그인하고 계속 학습
컨텐츠를 그만볼래?

필기노트, 하이라이터, 메모는 잘 쓰고 있어?

내보내줘
어떤 폴더에 저장할래?

컨텐츠 노트에는 총 0개의 폴더가 있어!

폴더 만들기
컨텐츠 만들기
만들기
신고했어요.

운영진이 검토할게요!

해당 유저를 차단했어요.

마이페이지에서 차단한 회원을 관리할 수 있어요.